Summary

The global particle size analysis market is projected to reach USD 7.73 billion by 2031 from USD 5.12 billion in 2025, at a CAGR of 6.5% from 2026 to 2031. Growing demand for pharmaceuticals, biologics, and nanotechnology is increasing the need for precise particle-size characterization to maintain product quality and performance. At the same time, the market is moving toward advanced, automated, and AI-driven analytical systems that enable faster, high-throughput, and more accurate measurements. “The laser diffraction segment held the largest share of the market in 2025.” Based on the technology, the particle size analysis market is segmented into laser diffraction, dynamic light scattering, imaging, Coulter principle, nanoparticle tracking analysis, sieve analysis, and other technologies. In 2025, the laser diffraction segment holds the largest share in the particle size analysis market. The laser diffraction segment is experiencing strong growth in the particle size analysis market due to its high accuracy, speed, and versatility across a wide particle size range, making it suitable for both wet and dry sample analysis across industries such as pharmaceuticals, chemicals, food, and mining. A key trend driving its adoption is the increasing demand for precise quality control and regulatory compliance, especially in biopharma and advanced materials, where consistent particle size is critical for product performance. “The wet dispersion segment held the largest share of the market in 2025.” Based on dispersion, the particle size analysis market is segmented into wet, dry, and spray dispersion. In 2025, the wet dispersion segment holds the largest share in the particle size analysis market. The wet dispersion segment is growing strongly in the particle size analysis market due to its ability to deliver highly accurate, reproducible, and reliable measurements for fine particles, suspensions, and emulsions, which are increasingly used in pharmaceuticals, nanotechnology, and advanced materials. A key trend driving this growth is the rising demand for liquid-based formulations such as biologics, drug suspensions, and chemical slurries, in which wet dispersion provides better particle separation and minimizes agglomeration, thereby improving data precision. “The healthcare industry segment held the largest share of the market in 2025.” Based on end user, the particle size analysis market is segmented into the healthcare industry (pharmaceutical and biotechnology companies, public and private research institutions, academic institutions), cosmetic industry, chemical and petroleum industry, mining, minerals, and cement industry, food and beverages industry, and other industries. In 2025, the healthcare industry segment holds the largest share in the particle size analysis market. The healthcare end-user segment is witnessing strong growth in the particle size analysis market due to the increasing demand for advanced drug development, biologics, and nanoparticle-based therapies, where precise particle characterization is critical for safety and efficacy. The rising focus on drug delivery systems, vaccines, diagnostic assays, and medical devices is further driving adoption, as particle size directly impacts bioavailability, stability, and performance. Additionally, growing investments in pharmaceutical R&D, expanding healthcare infrastructure, and strict regulatory requirements are pushing the need for accurate and reliable particle analysis solutions, making healthcare one of the fastest-growing segments in the market. “The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.” Asia-Pacific is emerging as the fastest-growing region in the particle size analysis market, driven by rapid industrialization, expanding pharmaceutical and chemical manufacturing, and increasing investments in nanotechnology and R&D across countries like China, India, Japan, and South Korea. The region benefits from strong government support, growing regulatory focus on product quality, and rising adoption of advanced analytical technologies in industries such as healthcare, electronics, and materials science. Additionally, the presence of cost-effective manufacturing, a large skilled workforce, and increasing global company expansion into emerging markets is accelerating demand for particle size analysis instruments, making Asia Pacific the key growth engine for the market. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16% • By Designation: C-level–10%, Director-level–14%, and Others–76% • By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3% As of 2025, the leading participants in the global particle size analysis market include Spectris (UK), HORIBA (Japan), Danaher (US), Anton Paar GmbH (Austria), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), Metller Toledo (US), Micromeritics Instrument Corporation (US), Microtrac Retsch GmbH (Germany), Shimadzu Corporation (Japan), Sympatec GmbH (Germany), and TSI (US), among others. These companies employ a range of strategic initiatives such as mergers and acquisitions, collaborations, partnerships, and product launches to strengthen their presence and expand their share in the global market. Research Coverage This report studies the particle size analysis market based on technology, dispersion, type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets by growth trends and forecasts revenue for the market segments across five main regions (and the respective countries within these regions). Reasons to Buy the Report The report will help market leaders/new entrants with information on the closest approximations of revenue for the overall particle size analysis market and its subsegments. This report will help stakeholders understand the competitive landscape and gain additional insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: • Analysis of key drivers (Growing demand for precision in pharmaceuticals & biologics), restraints (High cost of advanced instruments), opportunities (inline & real-time monitoring in manufacturing), and challenges (skill gap in advanced analytics) influencing the growth of the life science instrumentation market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the particle size analysis market • Market Development: Comprehensive information about lucrative markets–the report analyzes the particle size analysis market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the particle size analysis market • Competitive Assessment: In-depth assessment of market share, growth strategies, and service offerings of leading players like Spectris (UK), HORIBA (Japan), Danaher (US), Anton Paar GmbH (Austria), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), and others.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKET SEGMENTATION 26
1.3.2 INCLUSIONS & EXCLUSIONS 27
1.4 YEARS CONSIDERED 27
1.5 CURRENCY CONSIDERED 28
1.6 RESEARCH LIMITATIONS 28
1.7 STAKEHOLDERS 28
2 EXECUTIVE SUMMARY 29
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 29
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 31
2.3 DISRUPTIVE TRENDS IN PARTICLE SIZE ANALYSIS MARKET 31
2.4 HIGH GROWTH SEGMENTS 32
3 PREMIUM INSIGHTS 34
3.1 MARKET OVERVIEW 34
3.2 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY 35
3.3 REGIONAL SNAPSHOT OF PARTICLE SIZE ANALYSIS MARKET 35
4 MARKET OVERVIEW 36
4.1 INTRODUCTION 36
4.2 MARKET DYNAMICS 36
4.2.1 DRIVERS 37
4.2.1.1 Rapid Growth of mRNA, Lipid Nanoparticle (LNP), and Biologic Therapeutics Driving Demand for Precise Nanoparticle Characterization 37
4.2.1.2 AI-Enabled Automation and Intelligent Software Enhancing Operational Efficiency and Expanding Instrument Adoption 37
4.2.1.3 Increasing investments in pharmaceutical R&D 38
4.2.1.4 Stringent regulatory guidelines for product quality across industries 38
4.2.2 RESTRAINTS 39
4.2.2.1 High cost of particle size analyzers 39
4.2.2.2 Limitations in particle characterization range 39
4.2.3 OPPORTUNITIES 40
4.2.3.1 Increasing number of conferences and events 40
4.2.3.2 Expanding applications of particle size analysis in quality control and contamination detection across emerging industries 40
4.2.4 CHALLENGES 41
4.2.4.1 Lack of well-established distribution network among SMEs 41
4.2.4.2 Limitations of laser diffraction technology 42
4.3 UNMET NEEDS AND WHITE SPACES 42
4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 43
5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 45
5.1 KEY TECHNOLOGIES 45
5.1.1 LASER DIFFRACTION 45
5.1.2 COULTER PRINCIPLE (ELECTRICAL SENSING ZONE) 45
5.2 COMPLEMENTARY TECHNOLOGIES 45
5.2.1 DYNAMIC LIGHT SCATTERING (DLS) 45
5.2.2 NANOPARTICLE TRACKING ANALYSIS (NTA) 46
5.3 PATENT ANALYSIS 46
5.4 FUTURE APPLICATIONS 47
5.5 IMPACT OF AI/GEN AI ON PARTICLE SIZE ANALYSIS MARKET 48
5.5.1 TOP USE CASES AND MARKET POTENTIAL 48
5.5.2 BEST PRACTICES FOLLOWED BY COMPANIES IN PARTICLE SIZE ANALYSIS MARKET 48
5.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN PARTICLE SIZE ANALYSIS MARKET 49
5.5.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 49
5.5.5 CLIENT’S READINESS TO ADOPT AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET 50
5.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 50
5.6.1 KEY APPLICATIONS AND INDUSTRIAL OUTCOMES ENABLED BY PARTICLE SIZE ANALYZERS 51
6 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 52
6.1 DECISION-MAKING PROCESS 52
6.2 KEY STAKEHOLDERS IN BUYING PROCESS AND EVALUATION CRITERIA 52
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 52
6.2.2 KEY BUYING CRITERIA 53
6.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 54
6.4 UNMET NEEDS OF VARIOUS APPLICATIONS 55
7 REGULATORY ANALYSIS 56
7.1 NORTH AMERICA 56
7.1.1 US 56
7.1.1.1 Key regulatory bodies and government agencies 56
7.2 INDUSTRY STANDARDS 58
8 INDUSTRY TRENDS 60
8.1 PORTER’S FIVE FORCES ANALYSIS 60
8.1.1 THREAT FROM NEW ENTRANTS 61
8.1.2 THREAT FROM SUBSTITUTES 61
8.1.3 BARGAINING POWER OF SUPPLIERS 61
8.1.4 BARGAINING POWER OF BUYERS 61
8.1.5 INTENSITY OF COMPETITIVE RIVALRY 61
8.2 MACROECONOMIC OUTLOOK 62
8.2.1 INTRODUCTION 62
8.2.2 MACROECONOMIC INDICATORS 62
8.2.2.1 GDP trends and forecast 62
8.2.2.2 Trends in global particle size analysis market 62
8.3 VALUE CHAIN ANALYSIS 63
8.3.1 RAW MATERIAL SUPPLIERS 63
8.3.2 MANUFACTURERS 63
8.3.3 SALES & DISTRIBUTION 64
8.3.4 END USERS 64
8.4 ECOSYSTEM ANALYSIS 64
8.5 PRICING ANALYSIS 65
8.5.1 AVERAGE SELLING PRICE TREND, BY REGION 65
8.5.2 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER 67
8.6 TRADE DATA ANALYSIS 67
8.6.1 IMPORT DATA (HS CODE 903180) 67
8.6.2 EXPORT DATA (HS CODE 903180) 68
8.7 KEY CONFERENCES & EVENTS, 2026–2027 70
8.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 70
8.9 INVESTMENT & FUNDING SCENARIO 71
8.10 CASE STUDY ANALYSIS 72
8.10.1 CASE STUDY 1: ZETASIZER ULTRA VALIDATION FOR NANOPARTICLE CHARACTERIZATION 72
8.10.2 CASE STUDY 2: ZETPARTICLE CHARACTERIZATION FOR PHARMACEUTICAL APPLICATIONS 73
8.10.3 CASE STUDY 3: REAL-TIME VIABLE MONITORING IN PHARMACEUTICAL ASEPTIC MANUFACTURING 73
8.11 PARTICLE SIZE ANALYSIS MARKET - IMPACT OF US TARIFFS 73
8.11.1 INTRODUCTION 73
8.11.2 KEY TARIFF RATES 74
8.11.3 PRICE IMPACT ANALYSIS 74
8.11.4 IMPACT ON COUNTRY/REGION 75
8.11.4.1 US 75
8.11.4.2 Europe 75
8.11.4.3 Asia Pacific 75
8.11.5 IMPACT ON END USER 75
9 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY 76
9.1 INTRODUCTION 77
9.2 LASER DIFFRACTION 77
9.2.1 ADVANCED PARTICLE CHARACTERIZATION THROUGH AI-DRIVEN LASER DIFFRACTION TECHNOLOGIES TO DRIVE MARKET 77
9.3 DYNAMIC LIGHT SCATTERING 78
9.3.1 NEED FOR TRANSFORMING PARTICLE SIZE ANALYSIS THROUGH NEXT-GENERATION AI-DRIVEN DYNAMIC LIGHT SCATTERING (DLS) TECHNOLOGIES TO DRIVE MARKET 78
9.4 IMAGING 79
9.4.1 GROWTH OF IMAGING-BASED PARTICLE SIZE ANALYSIS THROUGH AUTOMATION AND AI INTEGRATION TO BOOST GROWTH 79
9.4.1.1 Dynamic imaging 80
9.4.1.2 Static imaging 81
9.5 NANOPARTICLE TRACKING ANALYSIS (NTA) 82
9.5.1 GROWTH OF NANOPARTICLE TRACKING ANALYSIS (NTA) IN ADVANCED SINGLE-PARTICLE CHARACTERIZATION AND BIOPHARMACEUTICAL APPLICATIONS TO BOOST GROWTH 82
9.6 COULTER PRINCIPLE 83
9.6.1 FOCUS ON STRENGTHENING GROWTH OF COULTER PRINCIPLE-BASED PARTICLE SIZE ANALYSIS THROUGH HIGH-PRECISION ELECTRICAL SENSING TO BOOST DEMAND 83
9.7 SIEVE ANALYSIS 84
9.7.1 DEVELOPMENT OF OTHER ADVANCED AND ACCURATE TECHNIQUES DISRUPTS GROWTH TO DRIVE MARKET 84
9.8 OTHER TECHNOLOGIES 85
10 PARTICLE SIZE ANALYSIS MARKET, BY END USER 87
10.1 INTRODUCTION 88
10.2 HEALTHCARE INDUSTRY 88
10.2.1 ADVANCING PRECISION DIAGNOSTICS THROUGH HIGH-RESOLUTION PARTICLE CHARACTERIZATION 88
10.2.2 PHARMA COS 90
10.2.2.1 Increasing Regulatory Focus on Drug Quality and Growing Outsourcing of Particle Engineering Driving Adoption of Particle Size Analysis 90
10.2.2.2 Process analytical technology 91
10.2.2.2.1 Growing Adoption of Process Analytical Technology (PAT) and Continuous Manufacturing Accelerating Demand for Real-Time Particle Size Monitoring 91
10.2.2.3 Other applications 92
10.2.2.3.1 Expanding particle characterization across complex pharmaceutical manufacturing workflows 92
 
10.2.3 BIOPHARMA COS 93
10.2.3.1 Rapid Expansion of Biologics and Nanomedicines Driving Demand for Advanced Particle Characterization Technologies 93
10.2.3.2 Process analytical technology 94
10.2.3.2.1 Increasing adoption of process analytical technology in biopharmaceutical manufacturing driving real-time particle characterization 94
10.2.3.3 Other applications 95
10.2.3.3.1 Enhancing biologics development through advanced nanoparticle characterization 95
10.2.4 PUBLIC & PRIVATE RESEARCH INSTITUTIONS 96
10.2.4.1 Emphasis on strengthening drug development pipelines with AI-enabled particle size characterization technologies to drive market 96
10.2.5 ACADEMIC INSTITUTIONS 97
10.2.5.1 Need for strengthening university research capabilities with advanced particle size characterization technologies to drive market 97
10.3 COSMETIC INDUSTRY 98
10.3.1 RAPID USE OF PRECISION PARTICLE SIZE CONTROL AND NANO-FORMULATION TECHNOLOGIES TO BOOST MARKET 98
10.4 CHEMICAL & PETROLEUM INDUSTRY 99
10.4.1 NEED FOR MAINTAINING REFINERY AND PETROCHEMICAL EFFICIENCY VIA PRECISION PARTICLE SIZE ENGINEERING AND PROCESS OPTIMIZATION TO DRIVE MARKET 99
10.5 MINING, MINERALS, AND CEMENT INDUSTRY 100
10.5.1 NEED TO ACCELERATE SUSTAINABLE MINING AND CEMENT PRODUCTION THROUGH DIGITAL PARTICLE SIZE MONITORING AND SMART GRINDING SYSTEMS TO BOOST GROWTH 100
10.6 FOOD & BEVERAGE INDUSTRY 101
10.6.1 GROWING CONCERN OVER FOOD QUALITY & SAFETY COMPLIANCE, ESPECIALLY IN EMERGING COUNTRIES, TO DRIVE MARKET 101
10.7 OTHER INDUSTRIES 102
11 PARTICLE SIZE ANALYSIS MARKET, BY TYPE 103
11.1 INTRODUCTION 104
11.2 BENCHTOP ANALYZERS 104
11.2.1 WIDE-SCALE USE FOR ENHANCED PRECISION AND EFFICIENCY IN MODERN LABORATORIES TO DRIVE MARKET 104
11.3 PORTABLE ANALYZERS 105
11.3.1 REVOLUTIONIZING LANDSCAPE OF PARTICLE SIZE ANALYSIS TO BOOST GROWTH 105
12 PARTICLE SIZE ANALYSIS MARKET, BY REGION 107
12.1 INTRODUCTION 108
12.2 NORTH AMERICA 108
12.2.1 US 112
12.2.1.1 Presence of large pharmaceutical and biotechnological companies to support market growth 112
12.2.2 CANADA 113
12.2.2.1 Increasing number of conferences on nanotechnology to drive growth 113
12.3 EUROPE 114
12.3.1 GERMANY 117
12.3.1.1 Increasing number of conferences and workshops to push adoption of particle size analyzers 117
12.3.2 UK 119
12.3.2.1 Academia and research institutions to play major role in increased demand for particle size analyzers 119
12.3.3 FRANCE 120
12.3.3.1 Public-private investments in biotechnology and pharmaceutical R&D to support adoption of particle size analyzers 120
12.3.4 ITALY 121
12.3.4.1 Strong pharmaceutical manufacturing and R&D activities to support adoption of particle size analyzers 121
12.3.5 SPAIN 122
12.3.5.1 Favorable environment for pharma and biotech companies and SMEs to support demand 122
12.3.6 REST OF EUROPE 124
12.4 ASIA PACIFIC 125
12.4.1 CHINA 129
12.4.1.1 Expanding pharmaceutical, nanotechnology, and research activities to drive demand for particle size analysis 129
12.4.2 JAPAN 130
12.4.2.1 Rising R&D expenditure to drive market 130
12.4.3 INDIA 131
12.4.3.1 Expanding pharmaceutical manufacturing and export capabilities to drive demand for particle size analysis 131
12.4.4 AUSTRALIA 132
12.4.4.1 Strong focus on pharmaceutical particle characterization and industrial particle analysis to support market growth 132
12.4.5 SOUTH KOREA 133
12.4.5.1 Strong government R&D investments and biotechnology innovation to drive market growth 133
12.4.6 REST OF ASIA PACIFIC 135
12.5 LATIN AMERICA 136
12.5.1 BRAZIL 139
12.5.1.1 Expanding healthcare infrastructure and pharmaceutical activities to support demand for particle size analysis 139
12.5.2 MEXICO 140
12.5.2.1 Expanding mining, petroleum, and pharmaceutical industries to support demand for particle size analysis 140
12.5.3 REST OF LATIN AMERICA 141
 
12.6 MIDDLE EAST & AFRICA 143
12.6.1 MULTIPLE CONFERENCES AND EXHIBITIONS TO PROMOTE UTILIZATION OF PARTICLE SIZE ANALYZERS 143
12.6.2 GCC COUNTRIES 145
12.6.2.1 Accelerating pharmaceutical quality infrastructure through advanced particle characterization 145
12.6.3 REST OF MIDDLE EAST & AFRICA 146
13 COMPETITIVE LANDSCAPE 148
13.1 OVERVIEW 148
13.2 KEY PLAYER STRATEGIES 148
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PARTICLE SIZE ANALYSIS MARKET 148
13.3 REVENUE SHARE ANALYSIS 150
13.4 MARKET SHARE ANALYSIS 150
13.4.1 PARTICLE SIZE ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025 150
13.5 COMPANY VALUATION & FINANCIAL METRICS 152
13.5.1 FINANCIAL METRICS 152
13.5.2 COMPANY VALUATION 153
13.6 BRAND/PRODUCT COMPARISON 153
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS 154
13.7.1 STARS 154
13.7.2 EMERGING LEADERS 154
13.7.3 PERVASIVE PLAYERS 154
13.7.4 PARTICIPANTS 154
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES 155
13.8.1 PROGRESSIVE COMPANIES 155
13.8.2 RESPONSIVE COMPANIES 155
13.8.3 DYNAMIC COMPANIES 156
13.8.4 STARTING BLOCKS 156
13.8.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2025 157
13.8.5.1 Company footprint 157
13.8.5.2 Regional footprint 157
13.8.5.3 Technology footprint 158
13.8.5.4 Dispersion footprint 159
13.8.5.5 Type footprint 159
13.8.5.6 End user footprint 160
13.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES 161
13.9.1 PROGRESSIVE COMPANIES 161
13.9.2 RESPONSIVE COMPANIES 161
13.9.3 DYNAMIC COMPANIES 161
13.9.4 STARTING BLOCKS 161
13.9.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 163
13.10 COMPETITIVE SCENARIO 165
13.10.1 PRODUCT LAUNCHES & APPROVALS 165
13.10.2 DEALS 165
13.10.3 EXPANSIONS 166
14 COMPANY PROFILES 167
14.1 KEY PLAYERS 167
14.1.1 SPECTRIS 167
14.1.1.1 Business overview 167
14.1.1.2 Products offered 168
14.1.1.3 Recent developments 170
14.1.1.3.1 Deals 170
14.1.1.4 MnM view 170
14.1.1.4.1 Key strengths 170
14.1.1.4.2 Strategic choices 170
14.1.1.4.3 Weaknesses and competitive threats 170
14.1.2 HORIBA 171
14.1.2.1 Business overview 171
14.1.2.2 Products offered 172
14.1.2.3 Recent developments 173
14.1.2.3.1 Product launches & approvals 173
14.1.2.4 Expansions 174
14.1.2.5 MnM view 174
14.1.2.5.1 Key strengths 174
14.1.2.5.2 Strategic choices 174
14.1.2.5.3 Weaknesses and competitive threats 174
14.1.3 DANAHER CORPORATION 175
14.1.3.1 Business overview 175
14.1.3.2 Products offered 176
14.1.3.3 MnM view 177
14.1.3.3.1 Key strengths 177
14.1.3.3.2 Strategic choices 177
14.1.3.3.3 Weaknesses and competitive threats 177
14.1.4 ANTON PAAR GMBH 178
14.1.4.1 Business overview 178
14.1.4.2 Products offered 178
14.1.4.3 Recent developments 179
14.1.4.3.1 Product launches & approvals 179
14.1.4.3.2 Deals 180
14.1.4.3.3 Expansions 180
 
14.1.4.4 MnM view 180
14.1.4.4.1 Key Strengths 180
14.1.4.4.2 Strategic Choices 181
14.1.4.4.3 Weaknesses and Competitive Threats 181
14.1.5 BETTERSIZE INSTRUMENTS LTD. 182
14.1.5.1 Business overview 182
14.1.5.2 Products offered 182
14.1.5.3 Recent developments 183
14.1.5.3.1 Product launches & approvals 183
14.1.5.3.2 Deals 184
14.1.5.3.3 Expansions 184
14.1.5.4 MnM view 185
14.1.5.4.1 Key strengths 185
14.1.5.4.2 Strategic choices 185
14.1.5.4.3 Weaknesses and competitive threats 185
14.1.6 NOVA VENTURES GROUP 186
14.1.6.1 Business overview 186
14.1.6.2 Products offered 186
14.1.7 FRITSCH GMBH 188
14.1.7.1 Business overview 188
14.1.7.2 Products offered 188
14.1.7.3 Recent developments 189
14.1.7.3.1 Product launches & approvals 189
14.1.8 LS INSTRUMENTS 190
14.1.8.1 Business overview 190
14.1.8.2 Products offered 190
14.1.8.3 Recent developments 191
14.1.8.3.1 Deals 191
14.1.8.3.2 Expansions 191
14.1.9 METTLER TOLEDO 192
14.1.9.1 Business overview 192
14.1.9.2 Products offered 193
14.1.10 VERDER SCIENTIFIC GMBH & CO. KG 194
14.1.10.1 Business overview 194
14.1.10.2 Products offered 194
14.1.10.3 Recent developments 195
14.1.10.3.1 Deals 195
14.1.10.3.2 Expansions 195
 
14.1.11 SYMPATEC GMBH 196
14.1.11.1 Business overview 196
14.1.11.2 Products offered 196
14.1.11.3 Recent developments 197
14.1.11.3.1 Expansions 197
14.1.12 SHIMADZU CORPORATION 198
14.1.12.1 Business overview 198
14.1.12.2 Products offered 199
14.1.12.3 Recent developments 200
14.1.12.3.1 Expansions 200
14.1.13 TSI 201
14.1.13.1 Business overview 201
14.1.13.2 Products offered 201
14.1.14 DANDONG HMKTEST INSTRUMENT CO., LTD. 203
14.1.14.1 Business overview 203
14.1.14.2 Products offered 203
14.1.15 MICROMERITICS INSTRUMENT CORPORATION 205
14.1.15.1 Business overview 205
14.1.15.2 Products offered 206
14.1.15.3 Recent developments 207
14.1.15.3.1 Deals 207
14.2 OTHER PLAYERS 208
14.2.1 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH 208
14.2.2 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD. 209
14.2.3 3P INSTRUMENTS 210
14.2.4 IZON SCIENCE LIMITED 211
14.2.5 CSC SCIENTIFIC COMPANY, INC. 212
14.2.6 INPROCESS-LSP 213
14.2.7 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC 214
14.2.8 APIX ANALYTICS 215
14.2.9 GENIZER LLC 216
14.2.10 TECHNOVALUE 217
15 RESEARCH METHODOLOGY 218
15.1 RESEARCH DATA 218
15.1.1 SECONDARY DATA 218
15.1.1.1 Key data from secondary sources 219
15.1.1.2 Objectives of secondary research 219
15.1.2 PRIMARY DATA 220
15.1.2.1 Objectives of primary research 221
15.1.2.2 Key industry insights 222
 
15.2 MARKET SIZE ESTIMATION 223
15.2.1 BOTTOM-UP APPROACH 224
15.2.1.1 Approach 1: Company revenue estimation approach 224
15.2.1.2 Approach 4: Primary interviews 225
15.2.2 TOP-DOWN APPROACH 225
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION 227
15.4 MARKET SHARE ASSESSMENT 228
15.5 RESEARCH ASSUMPTIONS 228
15.6 RESEARCH LIMITATIONS 228
15.7 RISK ASSESSMENT 229
16 APPENDIX 230
16.1 DISCUSSION GUIDE 230
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 234
16.3 CUSTOMIZATION OPTIONS 236
16.4 RELATED REPORTS 236
16.5 AUTHOR DETAILS 237

ページTOPに戻る

List of Tables/Graphs

TABLE 1 PARTICLE SIZE ANALYSIS MARKET: UNMET NEEDS 42
TABLE 2 STRATEGIC FOCUS OF TIER 1/2/3 PLAYERS 43
TABLE 3 KEY PATENTS, 2021–2026 47
TABLE 4 KEY COMPANIES IMPLEMENTING AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET 49
TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TECHNOLOGY 53
TABLE 6 KEY BUYING CRITERIA, BY TECHNOLOGY 54
TABLE 7 PARTICLE SIZE ANALYSIS MARKET: UNMET NEED ANALYSIS 55
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 57
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 57
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 58
TABLE 12 INDUSTRY STANDARDS FOR PARTICLE SIZE ANALYSIS MARKET 59
TABLE 13 PORTER’S FIVE FORCES ANALYSIS: PARTICLE SIZE ANALYSIS MARKET 60
TABLE 14 PARTICLE SIZE ANALYSIS MARKET: ROLE OF ECOSYSTEM 64
TABLE 15 AVERAGE SELLING PRICE OF LAB AUTOMATION EQUIPMENT, BY REGION,
2023–2025(USD THOUSAND) 66
TABLE 16 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER,
2025 (USD THOUSAND) 67
TABLE 17 IMPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 68
TABLE 18 EXPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 69
TABLE 19 LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 70
TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES 74
TABLE 21 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 77
TABLE 22 LASER DIFFRACTION: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 78
TABLE 23 DYNAMIC LIGHT SCATTERING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 79
TABLE 24 IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION) 80
TABLE 25 IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 80
TABLE 26 DYNAMIC IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 81
TABLE 27 STATIC IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 82
TABLE 28 NANOPARTICLE TRACKING ANALYSIS: PARTICLE SIZE ANALYSIS MARKET,
BY REGION, 2024–2031 (USD MILLION) 83
TABLE 29 COULTER PRINCIPLE: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 84
TABLE 30 SIEVE ANALYSIS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 85
TABLE 31 OTHER TECHNOLOGIES: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 86
TABLE 32 PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 88
TABLE 33 HEALTHCARE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY TYPE,
2024–2031 (USD MILLION) 89
TABLE 34 PHARMA AND BIOTECH COMPANIES: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 89
TABLE 35 HEALTHCARE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 89
TABLE 36 PHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 90
TABLE 37 PHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 91
TABLE 38 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET,
BY REGION, 2024–2031 (USD MILLION) 92
TABLE 39 OTHER APPLICATIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 92
TABLE 40 BIOPHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 93
TABLE 41 BIOPHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 94
TABLE 42 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET,
BY REGION, 2024–2031 (USD MILLION) 95
TABLE 43 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET,
BY REGION, 2024–2031 (USD MILLION) 95
TABLE 44 PUBLIC & PRIVATE RESEARCH INSTITUTIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 96
TABLE 45 ACADEMIC INSTITUTIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 97
TABLE 46 COSMETIC INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 98
TABLE 47 CHEMICAL & PETROLEUM INDUSTRY: PARTICLE SIZE ANALYSIS MARKET,
BY REGION, 2024–2031 (USD MILLION) 99
TABLE 48 MINING, MINERALS, AND CEMENT INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 100
TABLE 49 FOOD & BEVERAGE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 101
TABLE 50 OTHER END USERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 102
TABLE 51 PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION) 104
TABLE 52 BENCHTOP ANALYZERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 105
TABLE 53 PORTABLE ANALYZERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION,
2024–2031 (USD MILLION) 106
TABLE 54 PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 108
TABLE 55 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 109
TABLE 56 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 110
TABLE 57 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 110
TABLE 58 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION,
2024–2031 (USD MILLION) 110
TABLE 59 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE,
2024–2031 (USD MILLION) 111
TABLE 60 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER,
2024–2031 (USD MILLION) 111
TABLE 61 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUBINDUSTRY, 2024–2031 (USD MILLION) 111
TABLE 62 US: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 112
TABLE 63 US: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 113
TABLE 64 CANADA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 114
TABLE 65 CANADA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 114
TABLE 66 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 115
TABLE 67 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 115
TABLE 68 EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 116
TABLE 69 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION,
2024–2031 (USD MILLION) 116
TABLE 70 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION) 116
TABLE 71 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY END USER,
2024–2031 (USD MILLION) 117
TABLE 72 EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY,
BY SUB-TYPE, 2024–2031 (USD MILLION) 117
TABLE 73 GERMANY: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 118
TABLE 74 GERMANY: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 118
TABLE 75 UK: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 119
TABLE 76 UK: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 120
TABLE 77 FRANCE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 121
TABLE 78 FRANCE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 121
TABLE 79 ITALY: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 122
TABLE 80 ITALY: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 122
TABLE 81 SPAIN: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 123
TABLE 82 SPAIN: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 123
TABLE 83 REST OF EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 124
TABLE 84 REST OF EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 125
TABLE 85 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 126
TABLE 86 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 127
TABLE 87 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 127
TABLE 88 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION,
2024–2031 (USD MILLION) 127
TABLE 89 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 90 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY END USER,
2024–2031 (USD MILLION) 128
TABLE 91 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, SUB-TYPE, 2024–2031 (USD MILLION) 128
TABLE 92 CHINA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 129
TABLE 93 CHINA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 130
TABLE 94 JAPAN: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 130
TABLE 95 JAPAN: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 131
TABLE 96 INDIA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 132
TABLE 97 INDIA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 132
TABLE 98 AUSTRALIA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 133
TABLE 99 AUSTRALIA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 100 SOUTH KOREA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 134
TABLE 101 SOUTH KOREA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 134
TABLE 102 REST OF ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 135
TABLE 103 REST OF ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 136
TABLE 104 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 136
TABLE 105 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 137
TABLE 106 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 137
TABLE 107 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION,
2021–2028(USD MILLION) 137
TABLE 108 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 109 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER,
2024–2031 (USD MILLION) 138
TABLE 110 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION) 138
TABLE 111 BRAZIL: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 139
TABLE 112 BRAZIL: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 140
TABLE 113 MEXICO: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 141
TABLE 114 MEXICO: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE,
2024–2031 (USD MILLION) 141
TABLE 115 REST OF LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 142
TABLE 116 REST OF LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 142
TABLE 117 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 118 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 143
TABLE 119 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 144
TABLE 120 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION) 144
TABLE 121 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE,
2024–2031 (USD MILLION) 144
TABLE 122 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER,
2024–2031 (USD MILLION) 145
TABLE 123 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION) 145
TABLE 124 GCC COUNTRIES: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 146
TABLE 125 GCC COUNTRIES: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 146
TABLE 126 REST OF MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 147
TABLE 127 REST OF MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 147
TABLE 128 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 148
TABLE 129 PARTICLE SIZE ANALYSIS MARKET: DEGREE OF COMPETITION 151
TABLE 130 PARTICLE SIZE ANALYSIS MARKET: REGION FOOTPRINT 157
TABLE 131 PARTICLE SIZE ANALYSIS MARKET: TECHNOLOGY FOOTPRINT 158
TABLE 132 PARTICLE SIZE ANALYSIS MARKET: DISPERSION FOOTPRINT 159
TABLE 133 PARTICLE SIZE ANALYSIS MARKET: TYPE FOOTPRINT 159
TABLE 134 PARTICLE-SIZE ANALYSIS MARKET: END USER FOOTPRINT 160
TABLE 135 PARTICLE SIZE ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 163
TABLE 136 PARTICLE SIZE ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 164
TABLE 137 PARTICLE SIZE ANALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022 TO MARCH 2026 165
TABLE 138 PARTICLE SIZE ANALYSIS MARKET: DEALS, JANUARY 2022 TO MARCH 2026 165
TABLE 139 PARTICLE SIZE ANALYSIS MARKET: EXPANSIONS, JANUARY 2022 TO MARCH 2026 166
TABLE 140 SPECTRIS: COMPANY OVERVIEW 167
TABLE 141 SPECTRIS: PRODUCTS OFFERED 168
TABLE 142 SPECTRIS: DEALS, JANUARY 2021–APRIL 2026 170
TABLE 143 HORIBA: COMPANY OVERVIEW 171
TABLE 144 HORIBA: PRODUCTS OFFERED 172
TABLE 145 HORIBA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026 173
TABLE 146 HORIBA: EXPANSIONS, JANUARY 2021–APRIL 2026 174
TABLE 147 DANAHER CORPORATION: COMPANY OVERVIEW 175
TABLE 148 DANAHER CORPORATION: PRODUCTS OFFERED 176
TABLE 149 ANTON PAAR GMBH: COMPANY OVERVIEW 178
TABLE 150 ANTOR PAAR GMBH: PRODUCTS OFFERED 178
TABLE 151 ANTOR PAAR GMBH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2026 179
TABLE 152 ANTOR PAAR GMBH: DEALS, JANUARY 2021–APRIL 2026 180
TABLE 153 ANTOR PAAR GMBH: EXPANSIONS, JANUARY 2021–APRIL 2026 180
TABLE 154 BETTERSIZE INSTRUMENTS LTD.: COMPANY OVERVIEW 182
TABLE 155 BETTERSIZE INSTRUMENTS LTD.: PRODUCTS OFFERED 182
TABLE 156 BETTERSIZE INSTRUMENTS LTD: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2026 183
TABLE 157 BETTERSIZE INSTRUMENTS LTD: DEALS, JANUARY 2021–APRIL 2026 184
TABLE 158 BETTERSIZE INSTRUMENTS LTD.: EXPANSIONS, JANUARY 2021–APRIL 2026 184
TABLE 159 NOVA VENTURES GROUP: COMPANY OVERVIEW 186
TABLE 160 NOVA VENTURES GROUP: PRODUCTS OFFERED 186
TABLE 161 FRITSCH GMBH: COMPANY OVERVIEW 188
TABLE 162 FRITSCH GMBH: PRODUCTS OFFERED 188
TABLE 163 FRITSCH GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026 189
TABLE 164 LS INSTRUMENTS: COMPANY OVERVIEW 190
TABLE 165 LS INSTRUMENTS: PRODUCTS OFFERED 190
TABLE 166 LS INSTRUMENTS: DEALS, JANUARY 2021–APRIL 2026 191
TABLE 167 LS INSTRUMENTS: EXPANSIONS, JANUARY 2021–APRIL 2026 191
TABLE 168 METTLER TOLEDO: COMPANY OVERVIEW 192
TABLE 169 METTLER TOLEDO: PRODUCTS OFFERED 193
TABLE 170 VERDER SCIENTIFIC GMBH & CO. KG: COMPANY OVERVIEW 194
TABLE 171 VERDER SCIENTIFIC GMBH & CO. KG: PRODUCTS OFFERED 194
TABLE 172 VERDER SCIENTIFIC GMBH & CO. KG: DEALS, JANUARY 2021–APRIL 2026 195
TABLE 173 VERDER SCIENTIFIC GMBH & CO. KG: EXPANSIONS, JANUARY 2021–APRIL 2026 195
TABLE 174 SYMPATEC GMBH: COMPANY OVERVIEW 196
TABLE 175 SYMPATEC GMBH: PRODUCTS OFFERED 196
TABLE 176 SYMPATEC GMBH: EXPANSIONS, JANUARY 2021–APRIL 2026 197
TABLE 177 SHIMADZU CORPORATION: COMPANY OVERVIEW 198
TABLE 178 SHIMADZU CORPORATION: PRODUCTS OFFERED 199
TABLE 179 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–APRIL 2026 200
TABLE 180 TSI: COMPANY OVERVIEW 201
TABLE 181 TSI: PRODUCTS OFFERED 201
TABLE 182 DANDONG HMKTEST INSTRUMENT CO., LTD.: COMPANY OVERVIEW 203
TABLE 183 DANDONG HMKTEST INSTRUMENT CO., LTD.: PRODUCTS OFFERED 203
TABLE 184 MICROMERITICS INSTRUMENT CORPORATION: COMPANY OVERVIEW 205
TABLE 185 MICROMERITICS INSTRUMENT CORPORATION: PRODUCTS OFFERED 206
TABLE 186 MICROMERITICS INSTRUMENT CORPORATION: DEALS,
JANUARY 2021–APRIL 2026 207
TABLE 187 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH: COMPANY OVERVIEW 208
TABLE 188 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD.: COMPANY OVERVIEW 209
TABLE 189 3P INSTRUMENTS: COMPANY OVERVIEW 210
TABLE 190 IZON SCIENCE LIMITED: COMPANY OVERVIEW 211
TABLE 191 CSC SCIENTIFIC COMPANY, INC.: COMPANY OVERVIEW 212
TABLE 192 INPROCESS-LSP: COMPANY OVERVIEW 213
TABLE 193 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC: COMPANY OVERVIEW 214
TABLE 194 APIX ANALYTICS: COMPANY OVERVIEW 215
TABLE 195 GENIZER LLC: COMPANY OVERVIEW 216
TABLE 196 TECHNOVALUE: COMPANY OVERVIEW 217
TABLE 197 PARTICLE SIZE ANALYSIS MARKET: RESEARCH ASSUMPTIONS 228
TABLE 198 RISK ASSESSMENT ANALYSIS 229
FIGURE 1 MARKET SCENARIO 30
FIGURE 2 GLOBAL PARTICLE SIZE ANALYSIS MARKET, 2024–2031 30
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, 2022–2026 31
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PARTICLE SIZE ANALYSIS MARKET 31
FIGURE 5 HIGH-GROWTH SEGMENTS IN PARTICLE SIZE ANALYSIS MARKET, 2025 32
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH, IN TERMS OF VALUE, DURING FORECAST PERIOD 33
FIGURE 7 INCREASING RESEARCH ACTIVITIES IN NANOTECHNOLOGY TO DRIVE MARKET GROWTH 34
FIGURE 8 LASER DIFFRACTION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 35
FIGURE 9 CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 35
FIGURE 10 PARTICLE SIZE ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 36
FIGURE 11 PATENTS APPLIED AND GRANTED, 2016–2026 46
FIGURE 12 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TECHNOLOGY 53
FIGURE 13 KEY BUYING CRITERIA, BY TECHNOLOGY 53
FIGURE 14 PARTICLE SIZE ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 60
FIGURE 15 PARTICLE SIZE ANALYSIS MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 16 PARTICLE SIZE ANALYSIS: ECOSYSTEM ANALYSIS 64
FIGURE 17 AVERAGE SELLING PRICE TREND OF PRODUCTS BY REGION, 2023–2025 (USD) 66
FIGURE 18 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER,
2025 (USD THOUSAND) 67
FIGURE 19 IMPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 68
FIGURE 20 EXPORT DATA FOR HS CODE 903180, BY COUNTRY,
2021–2025 (USD THOUSAND) 69
FIGURE 21 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 71
FIGURE 22 INVESTMENT & FUNDING SCENARIO, 2019–2023 (USD MILLION) 71
FIGURE 23 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 72
FIGURE 24 DEAL VALUE OF INVESTMENT, BY KEY PLAYER, 2019–2023 (USD MILLION) 72
FIGURE 25 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET SNAPSHOT 109
FIGURE 26 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET SNAPSHOT 126
FIGURE 27 REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD BILLION) 150
FIGURE 28 MARKET SHARE ANALYSIS, 2025 151
FIGURE 29 EV/EBITDA OF KEY VENDORS 152
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 153
FIGURE 31 PARTICLE SIZE ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 153
FIGURE 32 PARTICLE SIZE ANALYSIS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2022 155
FIGURE 33 PARTICLE SIZE ANALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022 156
FIGURE 34 PARTICLE SIZE ANALYSIS MARKET: COMPANY FOOTPRINT 157
FIGURE 35 PARTICLE SIZE ANALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022 162
FIGURE 36 SPECTRIS: COMPANY SNAPSHOT, 2025 168
FIGURE 37 HORIBA: COMPANY SNAPSHOT, 2025 172
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT 2025 176
FIGURE 39 METTLER TOLEDO: COMPANY SNAPSHOT, 2025 193
FIGURE 40 SHIMADZU CORPORATION: COMPANY SNAPSHOT, 2025 199
FIGURE 41 PARTICLE SIZE ANALYSIS MARKET: RESEARCH DESIGN 218
FIGURE 42 PARTICLE SIZE ANALYSIS MARKET: BREAKDOWN OF PRIMARIES 220
FIGURE 43 PRIMARY SOURCES 221
FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 222
FIGURE 45 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 223
FIGURE 46 PARTICLE SIZE ANALYSIS MARKET SIZE ESTIMATION: APPROACH 1
(COMPANY REVENUE ESTIMATION) 224
FIGURE 47 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 225
FIGURE 48 DATA TRIANGULATION METHODOLOGY 227